We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
-2.34%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+402.82%
AUM
$52.6B
AUM Growth
-$3.21B
Cap. Flow
-$1.26B
Cap. Flow %
-2.4%
Top 10 Hldgs %
24.55%
Holding
1,245
New
126
Increased
333
Reduced
642
Closed
106

Top Buys

Rank Stock Value
1
IR icon
Ingersoll Rand
IR
+$286M
2
HUM icon
Humana
HUM
+$224M
3
LLY icon
Eli Lilly
LLY
+$143M
4
ABT icon
Abbott
ABT
+$110M
5
BALL icon
Ball Corp
BALL
+$104M

Sector Composition

Rank Sector Weight
1 Technology 20.38%
2 Healthcare 18.47%
3 Financials 12.77%
4 Consumer Discretionary 10.16%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$3.17B 6.02%
13,589,528
-82,071
-0.6% -$21.7M
AAPL icon
2
Apple
AAPL
$4.89T
$2.38B 4.52%
17,209,728
-474,534
-3% -$74.5M
AMZN icon
3
Amazon
AMZN
$2.5T
$1.36B 2.58%
12,020,516
-305,601
-2% -$38.6M
WMT icon
4
Walmart Inc
WMT
$871B
$1.07B 2.04%
24,756,069
-879,777
-3% -$38.5M
UNH icon
5
UnitedHealth
UNH
$382B
$924M 1.76%
1,830,180
+53,581
+3% +$28.2M
BAC icon
6
Bank of America
BAC
$435B
$903M 1.72%
29,913,806
-78,915
-0.3% -$2.64M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$823M 1.56%
8,557,169
-50,091
-0.6% -$5.59M
SCHW
8
Charles Schwab
SCHW
$177B
$768M 1.46%
10,689,272
+525,393
+5% +$36.5M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$68.8B
$760M 1.45%
1,103,833
-7,670
-0.7% -$4.83M
MRK icon
10
Merck
MRK
$324B
$759M 1.44%
8,809,184
-243,780
-3% -$21.8M
XOM icon
11
ExxonMobil
XOM
$651B
$738M 1.4%
8,458,221
+92,879
+1% +$8.48M
DHR icon
12
Danaher
DHR
$135B
$721M 1.37%
3,147,070
-107,107
-3% -$26.2M
UNP icon
13
Union Pacific
UNP
$183B
$719M 1.37%
3,688,494
-145,285
-4% -$32.1M
MCK icon
14
McKesson
MCK
$98.5B
$690M 1.31%
2,028,817
-2,831
-0.1% -$983K
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$676M 1.28%
4,980,646
+584,365
+13% +$94.7M
GS icon
16
Goldman Sachs
GS
$313B
$632M 1.2%
2,156,011
-10,586
-0.5% -$3.43M
TMO icon
17
Thermo Fisher Scientific
TMO
$211B
$618M 1.17%
1,217,783
-28,770
-2% -$16.1M
NOC icon
18
Northrop Grumman
NOC
$77B
$603M 1.15%
1,282,519
-464,444
-27% -$221M
TSLA icon
19
Tesla
TSLA
$1.24T
$596M 1.13%
2,245,581
+129,537
+6% +$36.2M
LLY icon
20
Eli Lilly
LLY
$1.07T
$567M 1.08%
1,753,036
+451,536
+35% +$143M
CI icon
21
Cigna
CI
$76.6B
$554M 1.05%
1,997,800
+283,323
+17% +$79.7M
COP icon
22
ConocoPhillips
COP
$147B
$546M 1.04%
5,335,461
+16,492
+0.3% +$1.65M
AMT icon
23
American Tower
AMT
$77.7B
$540M 1.03%
2,514,317
+198,199
+9% +$50.9M
C icon
24
Citigroup
C
$222B
$523M 1%
12,558,768
-37,629
-0.3% -$1.86M
RTX icon
25
RTX Corp
RTX
$287B
$491M 0.93%
5,994,835
+37,228
+0.6% +$3.37M

Similar funds

Putnam Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Putnam Investments held 1,245 positions worth $52.6B, down 5.8% from $55.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Putnam Investments's Q3 2022 filing shows 126 new, 333 increased, 642 reduced and 106 closed positions. Its largest new stake was iShares MSCI India ETF: 303,491 shares worth $12.4M. The largest sale was Johnson & Johnson, an estimated $518M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Putnam Investments's largest Q3 2022 buy was iShares MSCI India ETF: 303,491 shares worth $12.4M.
  • Putnam Investments added most to Ingersoll Rand in Q3 2022, an estimated $286M increase.
  • Putnam Investments's biggest Q3 2022 reduction was Johnson & Johnson, cutting an estimated $518M.
  • Putnam Investments fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $34.2M.
  • Putnam Investments's ten largest holdings make up 25% of its $52.6B portfolio in Q3 2022.
  • Putnam Investments opened 126 new positions and closed 106 in Q3 2022.
  • Putnam Investments's portfolio value fell 5.8% quarter-over-quarter to $52.6B.

Based on Putnam Investments's 13F filing for Q3 2022, filed 14 Nov 2022.